Total revenue reflects all sources, including product sales of Nuvax. The company provided this information in a Form 8 filing.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on NVAX:
- Novavax (NASDAQ:NVAX) Stock Sinks on Stock Offering, U.K. Vaccine Deal
- Novavax announces $125M common stock offering
- Novavax call volume above normal and directionally bullish
- Novavax Nuvaxovid COVID-19 vaccine approved in Canada for ages 12-17
- Novavax’s COVID-19 vaccine issued Emergency Use update by WHO